APTALIS PHARMA INC Net Income
APTALIS PHARMA INC reported Net Income of $20.07 million for the 3-month period ending 2011-12-31, per its 10-Q filed 2012-02-10.
Discontinued › Income Statement
us-gaap:NetIncomeLoss · last filed 2012-02-10
- APTALIS PHARMA INC net income (loss) attributable to parent for the quarter ending 2011-12-31 was $20.07M, a 1288.31% increase year-over-year.
- APTALIS PHARMA INC net income (loss) attributable to parent for the quarter ending 2011-09-30 was -$36.87M.
- APTALIS PHARMA INC net income (loss) attributable to parent for the quarter ending 2011-06-30 was -$80.79M.
- APTALIS PHARMA INC net income (loss) attributable to parent for the quarter ending 2010-12-31 was $1.45M.
- APTALIS PHARMA INC net income (loss) attributable to parent for fiscal 2011 was -$187.88M.
- APTALIS PHARMA INC net income (loss) attributable to parent for fiscal 2010 was -$170.37M.
- APTALIS PHARMA INC net income (loss) attributable to parent for fiscal 2009 was -$7.89M.
| Period end | Net Income (Loss) Attributable to Parent 3 month | Net Income (Loss) Attributable to Parent 6 month | Net Income (Loss) Attributable to Parent 9 month | Net Income (Loss) Attributable to Parent 12 month |
|---|---|---|---|---|
| 2011-12-31 | $20.07M 10-Q · filed 2012-02-10 | -$16.80M derived: sum of 2 quarters · filed 2012-02-10 | -$97.59M derived: sum of 3 quarters · filed 2012-02-10 | |
| 2011-09-30 | -$36.87M derived: 10-K 12 month − 10-Q 9 month · filed 2011-12-20 | -$117.66M derived: sum of 2 quarters · filed 2011-12-20 | -$187.88M 10-K · filed 2011-12-20 | |
| 2011-06-30 | -$80.79M 10-Q · filed 2011-08-12 | -$151.01M 10-Q · filed 2011-08-12 | ||
| 2010-12-31 | $1.45M 10-Q · filed 2012-02-10 | -$4.71M derived: sum of 2 quarters · filed 2012-02-10 | -$14.61M derived: sum of 3 quarters · filed 2012-02-10 | |
| 2010-09-30 | -$6.15M derived: 10-K 12 month − 10-Q 9 month · filed 2011-12-20 | -$16.05M derived: sum of 2 quarters · filed 2011-12-20 | -$170.37M 10-K · filed 2011-12-20 | |
| 2010-06-30 | -$9.90M 10-Q · filed 2011-08-12 | -$164.21M 10-Q · filed 2011-08-12 | ||
| 2009-09-30 | -$7.89M 10-K · filed 2011-12-20 |